Curetis expects a near term decision by FDA approving first product in US

By Christine Corrado / February 16, 2018 / www.proactiveinvestors.com / Article Link

CEO Oliver Schacht from Curetis (EN Amsterdam:CURE) tells Proactive Investors says their Unyvero Platform finds killer bugs in hospitals and tells doctors which antibiotics to use.

Schacht says they expect the FDA to approve the platform and first product in the U.S. which is a test for life-threatening ammonia. Schacht says he anticipates this to happen in the next few weeks.

 Meet Medusa Mining, Cora Gold, Group Eleven Resources Ltd., Harvest Minerals Ltd. and Crusader Resources Ltd at our event, London, 22 February 2018.Register here >>

Recent News

Gold stocks decline on flat metal and mixed equities

October 07, 2024 / www.canadianminingreport.com

Copper price expected to range from flat to slight gain in 2025

October 07, 2024 / www.canadianminingreport.com

China's gold holdings to central bank reserves still low

September 30, 2024 / www.canadianminingreport.com

China has broad effect on gold market

September 30, 2024 / www.canadianminingreport.com

Gold stocks mixed after previous week's huge gains

September 23, 2024 / www.canadianminingreport.com
See all >
Share to Youtube Share to Facebook Facebook Share to Linkedin Share to Twitter Twitter Share to Tiktok